Micro-needle Nanosensor Patch for Intradermal Analyte Monitoring
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional blood analyte detection methods require invasive procedures using hypodermic needles, causing pain and potential infections, and are resource-intensive, necessitating a non-invasive and cost-effective solution for monitoring analytes in interstitial fluid.
Innovation Solution
A skin-mountable device with micro-needles and nanosensors that penetrate the skin to interact with analytes in interstitial fluid, coupled with a reader device for optical detection of analyte presence or concentration, allowing for painless and minimally invasive monitoring.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If hypodermic needles are used for blood analyte detection, then analyte measurement is achieved, but patient pain and infection risk increase
Solution Approach 1:
The patent extracts the harmful hypodermic needle from the detection system and replaces it with micro-needles that penetrate only the epidermis to access interstitial fluid, thereby eliminating deep tissue trauma and infection risk while maintaining analyte detection capability
Solution Approach 2:
The patent introduces interstitial fluid as an intermediary medium between the external detection device and blood analytes. The micro-needles access interstitial fluid which contains analytes that equilibrate with blood, allowing indirect but accurate measurement without invasive blood sampling
2Measurement precision
If conventional blood testing methods are used, then analyte levels can be measured, but medical personnel and administration costs increase
Solution Approach 1:
The patent enables patients to perform analyte self-monitoring at home using the micro-needle device and portable reader, eliminating the need for medical personnel involvement in sample collection and basic testing, thereby reducing administration costs while maintaining measurement accuracy
Solution Approach 2:
The patent replaces complex laboratory-based mechanical and chemical analysis systems with a simplified optical detection system using fluorescent nanosensors and a portable reader, making the technology accessible for home use without requiring medical infrastructure
3Ease of operation
If micro-needles are used for skin penetration, then non-invasive monitoring is achieved, but device complexity increases
Solution Approach 1:
The patent merges multiple functions into the micro-needle structure itself: the micro-needles serve as both the penetration element and the substrate for mounting fluorescent nanosensors, eliminating the need for separate complex assembly components while achieving non-invasive monitoring
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables convenient, non-invasive monitoring of analytes like glucose levels, reducing the need for medical personnel and administration costs while avoiding needle-related complications.
Implementation Method 1
nanosensors comprising nanoparticles having a detectable label and configured to interact with a specific analyte present in interstitial fluid
Implementation Method 2
a reader device, wherein the reader device is configured to detect the target analyte via interaction with the skin-mountable device
Data Source
AI summary
A device and system for measuring and/or monitoring an analyte present on the skin is provided. The system includes a skin-mountable device that may be attached to an external skin surface and a reader device. The skin-mountable device includes a substrate, a plurality of micro-needles, and nanosensors. The micro-needles are attached to the substrate such that attachment of the substrate to an external skin surface causes to the micro-needles to penetrate into the epidermis, intradermis, or dermis. The nanosensors include a detectable label and are configured to interact with a target analyte present in the interstitial fluid in the epidermis, intradermis, or dermis. The reader device is configured to detect the analyte in interstitial fluid via interaction with the skin-mountable device.


